Associations of quality of life, pain, and self-reported arthritis with age, employment, bleed rate, and utilization of hemophilia treatment center and health care provider services: Results in adults with hemophilia in the HERO study

Patient Preference and Adherence

Volumn 9, Issue , 2015, Pages 1549-1560

  Forsyth, Angela L ^a   Witkop, Michelle ^b   Lambing, Angela ^c   Garrido, Cesar ^d   Dunn, Spencer ^e   Cooper, David L ^f   Nugent, Diane J ^g  

^a BioRx   (United States)

^b MUNSON MEDICAL CENTER   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d Asociacion Venezolana para la Hemofilia   (Venezuela)

^e Center for Inherited Blood Disorders   (United States)

^f NOVO NORDISK INC   (United States)

^g CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

Hemophilia; HERO; Pain; Quality of life

Indexed keywords

ANALGESIC AGENT;

ADULT; AGE; ANXIETY DISORDER; ARTHRALGIA; ARTHRITIS; ARTICLE; ATTITUDE TO HEALTH; BLEEDING; CLINICAL DECISION MAKING; DEPRESSION; EMPLOYMENT STATUS; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEMOPHILIA; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PAIN INTENSITY; PHYSICAL ACTIVITY; QUALITY OF LIFE; RESOURCE ALLOCATION; SELF CARE; SELF REPORT; VISUAL ANALOG SCALE;

EID: 84981724975     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/ppa.s87659     Document Type: Article

References (27)

1. World Federation of Hemophilia. Guidelines for the Management of Hemophilia. 2nd ed. Montreal, Quebec, Canada: World Federation of Hemophilia; 2013.
2. Stephensen D, Tait RC, Brodie N, et al. Changing patterns of bleeding in patients with severe haemophilia A. Haemophilia. 2009;15(6):1210–1214.
3. Rodriguez-Merchan EC. Musculoskeletal complications of hemophilia. HSS J. 2010;6(1):37–42.
4. Soucie JM, Cianfrini C, Janco RL, et al. Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors. Blood. 2004;103(7):2467–2473.
5. Aledort L, Bullinger M, von Mackensen S, Wasserman J, Young NL, Globe D. Why should we care about quality of life in persons with haemophilia? Haemophilia. 2012;18(3):e154–e157.
6. Globe D, Young NL, Von Mackensen S, Bullinger M, Wasserman J. Measuring patient-reported outcomes in haemophilia clinical research. Haemophilia. 2009;15(4):843–852.
7. Gringeri A, Von Mackensen S. Quality of life in haemophilia. Haemophilia. 2008;14(Suppl 3):19–25.
8. Fischer K, van der Bom JG, van den Berg HM. Health-related quality of life as outcome parameter in haemophilia treatment. Haemophilia. 2003;9(Suppl 1):75–81; discussion 82.
9. Pollak E, Muhlan H, von Mackensen S, Bullinger M; Haemo-QoL Group. The Haemo-QoL index: developing a short measure for health-related quality of life assessment in children and adolescents with haemophilia. Haemophilia. 2006;12(4):384–392.
10. von Mackensen S, Gringeri A. Quality of life in hemophilia. In: Handbook of Disease Burdens and Quality of Life Measures. Vol 3. Heidelberg, Germany: Springer; 2009:1895–1920.
11. Forsyth AL, Gregory M, Nugent D, et al. Haemophilia Experiences, Results and Opportunities (HERO) study: survey methodology and population demographics. Haemophilia. 2014;20(1):44–51.
12. Nugent D, Kalnins W, Querol F, et al. Haemophilia Experiences, Results and Opportunities (HERO) study: treatment-related characteristics of the population. Haemophilia. 2015;21(1):e26–e38.
13. Cassis FR, Buzzi A, Forsyth A, et al. Haemophilia Experiences, Results and Opportunities (HERO) study: influence of haemophilia on interpersonal relationships as reported by adults with haemophilia and parents of children with haemophilia. Haemophilia. 2014;20(4):e287–e295.
14. EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
15. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43(3):203–220.
16. Gringeri A, Mantovani LG, Scalone L, Mannucci PM. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group. Blood. 2003;102(7):2358–2363.
17. Bastani P, Pourmohamadi K, Karimi M. Quality of life in hemophilia complicated by inhibitors. Iran Red Crescent Med J. 2012;14(4):250–251.
18. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia. 1999;5(6):378–385.
19. Poon JL, Zhou ZY, Doctor JN, et al. Quality of life in haemophilia A: Hemophilia Utilization Group Study Va (HUGS-Va). Haemophilia. 2012;18(5):699–707.
20. Free MM. Cross-cultural conceptions of pain and pain control. Proc (Bayl Univ Med Cent). 2002;15(2):143–145.
21. Lasch KE. Culture and pain. Int Assoc Study Pain. 2002;10(5).
22. Noone D, O’Mahony B, Prihodova L. A survey of the outcome of prophylaxis, on-demand or combined treatment in 20–35 year old men with severe haemophilia in four European countries. Haemophilia. 2011;17(5):e842–e843.
23. Noone D, O’Mahony B, van Dijk JP, Prihodova L. A survey of the outcome of prophylaxis, on-demand treatment or combined treatment in 18–35-year old men with severe haemophilia in six countries. Haemophilia. 2013;19(1):44–50.
24. Hoots WK, Ebbesen LS, Konkle BA, et al. Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors. Haemophilia. 2008;14(3):466–475.
25. Neufeld EJ, Recht M, Sabio H, et al. Effect of acute bleeding on daily quality of life assessments in patients with congenital hemophilia with inhibitors and their families: observations from the dosing observational study in hemophilia. Value Health. 2012;15(6):916–925.
26. Fryback DG, Dunham NC, Palta M, et al. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care. 2007;45(12):1162–1170.
27. Revicki DA, Kawata AK, Harnam N, Chen WH, Hays RD, Cella D. Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample. Qual Life Res. 2009;18(6):783–791.